Arcturus Therapeutics (ARCT) Reports Q4 Loss of $1.03

Arcturus Therapeutics (NASDAQ: ARCT) reported Q4 EPS of ($1.03). Revenue for the quarter came in at $7.2 million.

For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• Hyatt Hotels (H) files mixed shelf